Diagnosis and treatment of type II necrotizing fasciitis in a child presenting with a minor abrasion, edema, and apparent bruising

Wounds

Volumn 21, Issue 3, 2009, Pages 74-78

  Eggert, Joan ^a   Di Giacomo, Adriana ^a   Paolo Vergineo, Pier ^a  

^a Intermountain Dixie Regional   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67249155214     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. O'Loughlin RE, Roberson A, Cieslak PR et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007;45(7):853-862.
2. Golger A, Citing S, Goldsmith CH, Pennie RA, Bain JR. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg. 2007; 119(6): 1803-1807.
3. Bingöl-Kologlu M, Yildiz RV, Alper B, et al. Necrotizing fasciitis in children: diagnostic and therapeutic aspects. J Pediatr Surg. 2007;42(11): 1892-1897.
4. Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Ant Surg. 2002;68(2):109-116.
5. Pandey A, Gangopadhyay AN, Upadhyaya VD. Necrotizing fasciitis in children and neonates: current concepts. J Wound Care. 2008;17(1):5-10.
6. Bryant AE, Bayer CR, Chen RY, Guth PH, Wallace RJ, Stevens DL. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes.J Infect Dis. 2005; 192(6): 1014-1022.
7. Akesson P, Rasmussen M, Mascini E, et al. Low antibody levels against cell wall- attached proteins of Streptococcus pyogenes predispose for severe invasive disease.J Infect Dis. 2004;189(5):797-804.
8. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology and determinants of mortality.J Bone Joint Surg Ant. 2003;85-A(8): 1454-1460.
9. Escobar SJ, Slade JB Jr, Hunt TK, Cianci P. Adjuvant hyperbaric oxygen therapy (HB02) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med. 2005;32(6):437-443.
10. Hyperbaric Oxygen 2003: Indications and Results. The Hyperbaric Oxygen Therapy Committee Report. Feldmeier JJ, ed. Undersea Hyperb Med Soc. 2003:19-26, 69-78.
11. Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28(4):800-807.
12. Jeschke MG, Rose C, Angele P, Füchtmeier B, Nerlich MN, Bolder U. Development of new reconstructive techniques: use of Integra in combination with fibrin glue and negative-pressure therapy for reconstruction of acute and chronic wounds. Plast Reconstr Surg. 2004;113(2):525-530.
13. Eggert JV, Van Gils C, Gardner K, Forbes B, Rhodes R, Van Norman S. Combined treatment modalities of hyperbaric oxygen therapy, bilayer matrix wound dressing, and negative pressure therapy in patients with failed temporoparietal fascia flaps. WOUNDS. 2007;19(5):120-123.
14. Hansen SL, Voigt DW, Paul CN. A retrospective study on the effectiveness of intranasal midazolam in pediatric burn patients.J Burn Care Rehabil. 2001;22(l):6-8.
15. Henry DB, Foster RL. Burn pain management in children. Pediatr Clin North Am. 2000;47(3):681-698.